Their relevance for peptide therapeutics lies in their ability to physically protect sensitive APIs while offering tunable size, composition, and surface properties
The cardiovascular safety of TRESIBA was evaluated in one double blinded, event driven trial of 2 year median duration in patients with type 2 diabetes at high risk of cardiovascular events [see Clinical Studies ]
hold a published patent (WO/2023/180570) that covers the in vitro method for identifying anti-senescence compounds based on detecting the binding of said compound in the presence of at least one phosphorylated amino acid in the transcription activation domain (TAD) domain of mammalian protein p53
As a GLP-1 receptor agonist, Semaglutide mimics the bodys natural GLP-1 hormone, which is released after eating
Every shipment includes a Certificate of Analysis confirming identity, purity, and potency, so when patients ask questions, we have clear, defensible answers
Wegovy may not be suitable for everyone
